CD8A and neoplasm: CRC-bearing mouse models treated with adenoviral B7-H3 showed suppressed tumor growth and reduced secondary metastasis occurrence with significantly higher frequencies of IFN-γ-producing CD8+ T cells and higher IL-12 levels than the control group mice (43, 44).